Brought to you by 
SmithKline, Incyte form 50/50 diagnostics JV, diaDeXus LLC
13 Jul 1999
Executive Summary
SmithKline Beecham and Incyte (genomic databases) formed a 50/50 molecular diagnostics joint venture, diaDexus LLC, to develop tests based on genomic data from Incyte and SB/Human Genome Sciences databases.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- Joint Venture
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com